Study: Supplement May Block Amyloid Plaques in Alzheimer’s
Summary: A new study from Kindai University demonstrates that oral arginine, a naturally occurring amino acid and clinical chemical chaperone, can substantially inhibit amyloid-β (Aβ) aggregation in laboratory and animal models of Alzheimer’s disease. The researchers report that arginine prevents Aβ42 from forming toxic aggregates, reduces plaque burden, and diminishes neuroinflammation in both fruit fly … Read more